As the pace of innovation further accelerates in 2021, and the need to get new devices to market intensifies, maintaining adherence to regulatory controls is not enough.
Digital health tools and technology have the potential to dramatically improve the patient care experience, but the shift requires purposeful coordination and planned architecture.
We all need to play a role to drive the innovative changes necessary and not wait for someone else to do it.
When a company does not take action to become more environmentally responsible, it risks losing access to global markets.
The program highlights the agency’s commitment to improving safety and supporting innovation, and is a welcome counterpart to the Breakthrough Devices Program.
It’s time to take stock on what temporary measures need to be made permanent to grow as an industry.
Increased access to care is a vital part of the vision to innovate the delivery of healthcare.
The normalization of digital healthcare will go a long way toward driving uptake of new technologies.
RPM products with medical-grade sensors can play a dynamic role in developing personalized medicine.
Quantum computing has spurred the development of new breakthroughs in life sciences from using machine learning methods to diagnose illnesses sooner to identifying materials to make more efficient devices.